Profile
Niven R.
Narain is the founder.
He founded Berg LLC in 2006 and holds the title of Manager.
Currently, he is the President & Chief Executive Officer at BPGbio Inc.
Niven R. Narain active positions
Companies | Position | Start |
---|---|---|
Berg LLC
Berg LLC Pharmaceuticals: MajorHealth Technology Berg LLC operates as a biopharmaceutical company, which focuses on taking a bold back to biology approach to therapeutic discovery using its Interrogative Biology platform. Its therapeutics include cancer metabolism and BPM 31510, chemotherapy induced alopecia and BPM 315453, neurology-discovery program, and metabolic disease-discovery program. The company was founded by Carl Edwin Berg, Mitch Gray, and Niven R. Narain in 2006 and is headquartered in Framingham, MA. | Corporate Officer/Principal | - |
BPGbio Inc
BPGbio Inc BiotechnologyHealth Technology BPGbio Inc is a clinical stage biopharma and diagnostics company that focuses on oncology, neurology, and rare diseases. BPGbio's approach is underpinned by NAI, its proprietary interrogative biology platform, protected by over 400 US and international patents, the world's largest clinically annotated non-governmental biobank, and exclusive access to the most powerful supercomputer in the world. The private company is based in Framingham, MA, and has subsidiaries in the United States. The company has a portfolio of AI-developed therapeutics, including several in late-stage development. The CEO of the company is Niven R. Narain. | Chief Executive Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Berg LLC
Berg LLC Pharmaceuticals: MajorHealth Technology Berg LLC operates as a biopharmaceutical company, which focuses on taking a bold back to biology approach to therapeutic discovery using its Interrogative Biology platform. Its therapeutics include cancer metabolism and BPM 31510, chemotherapy induced alopecia and BPM 315453, neurology-discovery program, and metabolic disease-discovery program. The company was founded by Carl Edwin Berg, Mitch Gray, and Niven R. Narain in 2006 and is headquartered in Framingham, MA. | Health Technology |
BPGbio Inc
BPGbio Inc BiotechnologyHealth Technology BPGbio Inc is a clinical stage biopharma and diagnostics company that focuses on oncology, neurology, and rare diseases. BPGbio's approach is underpinned by NAI, its proprietary interrogative biology platform, protected by over 400 US and international patents, the world's largest clinically annotated non-governmental biobank, and exclusive access to the most powerful supercomputer in the world. The private company is based in Framingham, MA, and has subsidiaries in the United States. The company has a portfolio of AI-developed therapeutics, including several in late-stage development. The CEO of the company is Niven R. Narain. | Health Technology |
- Stock Market
- Insiders
- Niven R. Narain